Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway

British Journal of Cancer, Published online: 30 October 2020; doi:10.1038/s41416-020-01135-6Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway

Source: British Journal of Cancer - October 30, 2020 Category: Cancer & Oncology Authors: Lehe Yang Feng Zhou Yan Zhuang Yanan Liu Lingyuan Xu Haiyang Zhao Youqun Xiang Xuanxuan Dai Zhiguo Liu Xiaoying Huang Liangxing Wang Chengguang Zhao Source Type: research